Navigation Links
NYC-area 1st: Morgan Stanley Children's Hospital performs transcatheter pulmonary valve replacement
Date:8/22/2007

NEW YORK (Aug. 21, 2007) -- A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.

The minimally invasive procedure, which involves the implantation of the first-ever catheter-based pulmonary valve replacement, is currently performed by interventional cardiologists at Morgan Stanley Children's Hospital of NewYork-Presbyterian and Columbia University Medical Center -- the only New York City site and one of only three sites nationally that is offering the procedure as part of an ongoing clinical research trial.

Currently, babies with absent or defective pulmonary valves may require open-heart surgery to implant a valved-conduit (a two-inch tube with a valve inside) to open the connection between their right ventricle and pulmonary artery. But because the conduit's lifespan is limited by deterioration and patient growth, traditionally the invasive surgery must be repeated several times as the patient grows older.

The new transcatheter pulmonary valve (TPV) is designed to extend the lifespan of the conduit by improving the natural function of the patient's heart. The goal is to reduce the need for multiple open-heart surgeries.

Dr. William Hellenbrand leads the study at Morgan Stanley Children's Hospital of NewYork-Presbyterian, where he is chief of pediatric cardiology and director of the Pediatric Cardiac Catheterization Laboratory. He is also professor of clinical pediatrics at Columbia University College of Physicians and Surgeons.

"This unique and innovative procedure allows us to replace the patient's heart valve by threading the device through a vein in their leg and into their heart. Previous research has shown that these patients can expect a reduced need for potentially risky open-heart surgery -- and therefore improved quality of life," Dr. Hellenbrand explains.
'/>"/>

Contact: Belinda Mager
bem9048@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. RSV Hits Winnipeg Childrens Hospital
2. Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending
3. Childrens Health Program Covering More Adults Than Children
4. Nutritious Diet Help Improve Childrens Academic Performance
5. Oracle Corp. to help build worlds first "Digital Hospital"
6. Apollo Hospitals to consider listing on US Bourses in 2003
7. The World Bank funds private Hospital in India
8. Greater volume hospitals better for stroke
9. Spurt in hospital admissions following football shoot-outs
10. Machines take over the battle against hospital bugs
11. New way to control hospital infection

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Nov. 9 Highlighting a commitment...th advanced entertainment and digital display tech...atest Long-Term Care and Hospital Grade LCD HDTVs ... for the Aging 2009 annual meeting and exposition ... new line of "HealthView(TM)" Long-Term Care LCD H...
(Date:11/9/2009)...K, Nov. 9 /PRNewswire/ -- Phoenix House , the...e treatment and prevention program, announced toda...lly and internationally recognized leader in subst...al Officer, effective January 1, 2010. ,, "Dr...e abuse treatment research and her work has result...
(Date:11/9/2009)...ents Support Experimental Procedure for Preteen So...swire/ -- For parents of children with cancer, the...e steadily improved for decades. Among the bad new...nfertility. ,, Boys diagnosed with cancer who...y to preserve their fertility: before undergoing c...
(Date:11/9/2009)...ildren,s Research Hospital and the University of F...aboration to provide proton therapy for St. Jude p...the first clinical study to evaluate the use of pr...unger than 3 years old. , Under the clinical p...roton therapy at the UF Proton Therapy Institute i...
(Date:11/9/2009)...10 million people around the world suffer from cat...Frankfurt and his coauthors discuss cataract surge...the current issue of Deutsches rzteblatt Internat...533;). , Blindness is usually due to opacificati...0 cataract operations are performed each year. Cat...
Breaking Medicine News(10 mins):Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2
...ce in Primary and Key Secondary Endpoints at Both,...aintenance Effects Seen in,the First Phase II Stud...FORD, England, October 16 /PRNewswire-FirstCall/,-...omnia patients with daytime sleepiness. These top-...
...16 Many routine surgical biopsies,could become a ...aring,reviewing and diagnosing noninvasive digital...d Inc.,s VivaNet(TM) telemedicine server and its,V...urgically biopsy many,patients. "VivaScope imaging...
...utive to Lead Growing Medical Device Firm, SANTA ...eading provider of innovative medical devices used...ons for the minimally invasive treatment of,deep v...utive Officer. Mr. Cramer joined Bacchus Vascular...
...he following is an,event announcement from the Bro...00 a.m. - 10:30 a.m., The Brookings Institution ...shington, DC, Donor assistance for health-related...ed to achieve the Millennium,Development Goals. Ad...
... Wyeth (NYSE: WYE ),confirmed today that it will...rrester v. Wyeth cases in the Second Judicial Dist...al motions to The Honorable Robert H. Perry,who pr...General Counsel.,"The events of last week and the ...
... 15 HealthSouth,Corporation (NYSE: HLS ) today a...at 8:30 a.m. Eastern Time on Tuesday, November 6, ... of 2007. The conference call may be accessed by ...mately 10 minutes before the,start of the call to ...
Other Medicine News:Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 2Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 3Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 4Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 5Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 6Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 7Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 8Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 9Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 10Health News:VivaScope(R) Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients 2Health News:Bacchus Vascular Names Scott Cramer as President and CEO 2Health News:Brookings: Donor Perspectives on Innovative Financing for Global Health 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 3Health News:HealthSouth Announces Date of Third Quarter Earnings Conference Call 2
(Date:11/9/2009)...wire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT )...athologists, oncologists and the pharmaceutical in...ke presentations at two upcoming investor conferen... will be made at the Lazard Capital Markets Sixth ...sday, November 17. The conference will be held at ...
(Date:11/7/2009)...re/ -- Most patients with hereditary angioedema (H...g HAE attack giving the patients sufficient time t...sociated with that attack, according to survey fin... of Allergy, Asthma & Immunology (ACAAI) Annua...atigue and nausea, which occur frequently before a...
(Date:11/6/2009).... 6 In consultation with the U.S. ...r Healthcare, Division of McNEIL-PPC, Inc., is ini...product lots of TYLENOL® Arthritis Pain Caple...PEN CAP. McNeil is initiating the recall after ide...ated with these lots that led to a small number of...
Breaking Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Ash Stevens Plans 246 Million Facility Expansion to Bolster CMC Capabilities 14293 1Ash Stevens Plans 246 Million Facility Expansion to Bolster CMC Capabilities 14293 2Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 1Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 2Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 3Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 4Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 5Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 6Have a Healthier Halloween with Tigers Milk 28R 29 58516 1Have a Healthier Halloween with Tigers Milk 28R 29 58516 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: